A new molecular scissors act like a GPS to improve genome editing
Researchers from the University of Copenhagen (Denmark), led by the Spanish researcher Guillermo Montoya, have discovered how Cpf1, a new molecular scissors unzip and cleave DNA. This member of the CRISPR-Cas family displays a high accuracy, capable of acting like a GPS in order to identify its destination within the intricate map of the genome. The high precision of Cpf1 will improve the use of this type of technology in repairing genetic damage and in other medical and biotechnological applications.
A scientific team from in the Novo Nordisk Foundation Center for Protein Research (NNF-CPR), at the University of Copenhagen, has succeeded in visualizing and describing how a new system for genome editing, known as Cpf1, works. This protein belongs to the Cas family and enables the cleavage of double stranded DNA, thus allowing the initiation of the genome modification process. The results of the study have been published in the journal Nature.
Guillermo Montoya, a researcher in the fields of biochemistry and molecular biology who led the study, explains to SINC that the new molecular scissors “will enable us to more safely modify and edit the instructions written in the genome, due to the utmost precision of the target DNA sequence recognition”.
The new molecular scissors achieve complementary ends instead of blunt, as happens with Cas9, which facilitates the insertion of a DNA sequence
The CRISPR Cas9 system for cutting and paste genome sequences is already being used to modify animal and plant genomes. Also to treat illnesses, such as cancer and retinal diseases, in humans and its applications are growing very fast.
X-Ray Crystallography Technique
Researchers across the world are trying to perfect this genome editing technique with the aim of making it yet more precise and efficient. To achieve this, they have also focused on other proteins that specifically cut DNA, such as Cpf1, whose manipulation can direct them to specific locations in the genome. Montoya’s team has achieved this using an X-ray Crystallography to decipher the molecular mechanisms controlling this process.
“We radiated the crystals of the Cpf1 protein using X-rays to be able to observe its structure at atomic resolution, enabling us to see all its components,” points out the co-author of this study. “X-ray diffraction is one of the main biophysical techniques used to elucidate biomolecular structures,” he continues.
In his opinion, “the main advantage of Cpf1 lies in its high specificity and the cleaving mode of the DNA, since it is possible to create staggered ends with the new molecular scissors, instead of blunt-ended breaks as is the case with Cas9, which facilitates the insertion of a DNA sequence.”
“The high precision of this protein recognising the DNA sequence on which it is going to act functions like a GPS, directing the Cpf1 system within the intricate map of the genome to identify its destination. In comparison with other proteins used for this purpose, it is also very versatile and easy to be reprogrammed,” Montoya adds.
The high precision DNA sequence recognition functions as a GPS that directs the tool within the intricate map of the genome
Genetic diseases and tumours
These properties make this system “particularly suitable for its use in the treatment of genetic diseases and tumours,” he affirms.
The team has previously worked with the French biotechnology company Celletics on the use of meganucleases –other proteins that can be redesigned to cut the genome in a specific location– to treat certain types of leukemia.
The new technology “can also be used to modify microorganisms, with the aim of synthesising the metabolites required in the production of drugs and biofuels,” adds Montoya.
This researcher, from Getxo (Biscay, Spain), says that there are many companies interested in this new technology. They are mostly from the biotechnology sector in the field of microorganism manipulation, but cannot be named due to confidentiality agreements.
Learn more:A new molecular scissors act like a GPS to improve genome editing
The Latest on: Genome editing
[google_news title=”” keyword=”genome editing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- BSM arranges workshop on CRISPR-Cas9 Gene Editing: A new era in molecular biologyon May 12, 2024 at 3:36 am
Bangladesh Society of Microbiologists (BSM) arranged a comprehensive 5-day workshop providing hands-on training on CRISPR experimental design to 20 candidates in the first phase of the workshop ...
- China fast-tracks edited wheat genome as part of food security driveon May 12, 2024 at 2:50 am
The edit, which helps the crop resist a common fungal infection, was approved within an unusually short period It is the first wheat genome edit approved in China, which shows country's interest in ...
- CRISPR and Genome Editing – Webinars and Online Eventson May 9, 2024 at 9:46 pm
This process requires a large number of precision genome edits to be made in single cells that can ... colony picking with that improve single-cell outgrowth and increase gene editing efficiency. Cell ...
- Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editingon May 9, 2024 at 7:00 am
NDAQ:SGMO) Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing ...
- Editas Medicine’s Innovative In Vivo Gene Editing Approach and Positive Clinical Trial Prospects Bolster Buy Ratingon May 9, 2024 at 3:26 am
Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
- Team develops an epigenome editing toolkit to dissect the mechanisms of gene regulationon May 8, 2024 at 5:00 pm
The set of epigenetic modifications of a cell's genome is referred to as the epigenome. In a study just published in Nature Genetics, scientists from the Hackett Group at EMBL Rome have developed a ...
- An epigenome editing toolkit to dissect the mechanisms of gene regulationon May 8, 2024 at 5:00 pm
A study from the Hackett group at EMBL Rome led to the development of a powerful epigenetic editing technology. The system unlocks the ability to precisely program chromatin modifications at any ...
- ASGCT 2024: Mammoth Sizes Up Genome Editing Opportunitieson May 8, 2024 at 11:16 am
We catch up with Mammoth Biosciences CSO Lucas Harrington after his ASGCT presentation. Harrington lays out his company's big plans in developing a range of therapeutic options using miniature Cas ...
- CRIPSR gene editing leads to improvements in vision for people with inherited blindness, clinical trial showson May 6, 2024 at 9:14 am
Results of a phase 1/2 clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the ...
- Measuring Mutagenesis with Precision Genome Editingon May 3, 2024 at 5:14 am
A new prime editing sensor library targeting p53 mutations allowed scientists to interrogate thousands of tumor genotypes as they arose in endogenous contexts.
via Google News and Bing News